Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa
This study is ongoing, but not recruiting participants.
Sponsor:
Vakzine Projekt Management GmbH
Collaborators:
Children's Infectious Diseases Clinical Research Unit (KID-CRU), South Africa
Triclinium Johannesburg, South Africa
Stellenbosch University, Cape Town, South Africa
HJ-CTC George, South Africa
Information provided by (Responsible Party):
Vakzine Projekt Management GmbH
ClinicalTrials.gov Identifier:
NCT01479972
First received: November 18, 2011
Last updated: May 30, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |